Baijin Life Science Holdings (1466.HK) Earnings Analysis
Baijin Life Science Holdings (1466.HK) has no confirmed upcoming earnings date. Trailing P/E -25.12.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 1466.HK next report earnings?
No confirmed upcoming earnings date is currently scheduled for 1466.HK. This page updates as the calendar is published.
1466.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2024-11-29 | -0.0092 HKD | n/a | n/a | n/a |
| 2024-07-31 | -0.0079 HKD | n/a | n/a | n/a |
1466.HK valuation and analyst view
| Trailing P/E | -25.12 |
|---|---|
| Trailing EPS | -0.03073 HKD |
| Price / book | 6.72 |
| Dividend yield | 0.00% |
| Market cap | 0.77B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Baijin Life Science Holdings (1466.HK)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 1466.HK. This page updates as the calendar is published.
Did 1466.HK beat earnings last quarter?
Consensus estimate data was not available for 1466.HK's 2024-11-29 report.
What is 1466.HK's current P/E ratio and EPS?
1466.HK trades at a trailing P/E of -25.12 on trailing EPS of -0.030730988006093123 HKD.
What do analysts rate 1466.HK?
1466.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.